Thomas A. Zalewski
General Counsel, Aquestive Therapeutics, Inc.
Companies
- Aquestive Therapeutics, Inc.General counsel Apr 10, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aquestive Therapeutics, Inc. AQST100,000 shares2$375.5K at $3.75May 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 18, 2026Granted 100,000 shares of Aquestive Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2